A recent study reveals that people who discontinue popular weight-loss injections like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who halt traditional lifestyle programs.
Published data in a leading health publication demonstrates that while overweight individuals can lose substantial amounts of their body weight while using the jabs, the weight returns at an average rate of 0.8 kg per month once they quit.
"People purchasing these medications need to be informed of the potential of rapid weight regain when the therapy concludes," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery implies a return to original mass in about a year and a half.
Comparing Treatments
The study, which examined 37 of trials involving over 9,000 of participants, compared the results of GLP-1 agonists with other pills.
Scientists note that people who lose weight through diet and exercise typically see a more gradual creep back—around 0.1 kg a month—once they finish.
Understanding the Fast Rebound
Experts propose the way of the injections is key to understanding the accelerated rebound.
These medications mimic a body's own chemical called GLP-1, which moderates feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than normal may cause the system to produce less of its endogenous hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication leads to hunger is no longer kept in check, making binge eating a significant risk."
A Chronic Disease?
Medical guidelines recommend the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians contend that, due to the high risk of weight regain, the treatment is often long-term.
This perspective is supported by drug manufacturers, who note that the results "emphasize the chronic character of obesity," akin to managing diseases like hypertension.
Patient Accounts
Individuals who have discontinued the medication explain a sudden resurgence of hunger.
"It was like a trigger that goes on and I was suddenly ravenous," said an individual.
This challenge is worsened if users have not adopted permanent dietary or behavioural modifications during treatment.
Significant Adoption
Recent estimates indicate that millions of adults in the UK have tried these injections in the past year, with demand continuing to grow.
- Use is greater among females compared to males.
- The middle-aged demographic shows the highest level of interest.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, experts stress that while these medications are powerful agents for weight loss, they are not a magic fix and long-term success relies on integrated lifestyle management.
